The market of In Vitro Diagnostics (IVD) in India has observed a phenomenal growth due to several factors such as rising health awareness, new generation IVD products, and the rising incidence of chronic diseases. Currently, the market has a CAGR of more than 10 percent owing to the expanding middle class, better healthcare facilities, and the increasing demand for pointof- care testing (POCT). The Indian IVD market is characterized by rapid adoption of advanced diagnostic technologies especially in the molecular diagnostics, immunoassays and clinical chemistry. The COVID-19 outbreak has galvanized this growth because of the focus on accurate and fast diagnosis, which has boosted investments in IVD technologies. Further, the government has also been instrumental in improving the diagnostic facilities in the country, especially in the rural and the urban sectors.
An... >>More
.jpg)
Fabi Carino, Director - HR, Medrisk
Raghu Malhotra, President, Global Enterprise Growth, Mastercard
Bilal Ahmed Javeri, CIO, Lucky Motor Corporation
Alex Tan, CEO, ZICO Capital
Rajesh Kumar Singh, Global Head - HR, KPIT
